A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

Conditions: Non-small Cell Lung Cancer Stage IV Interventions: Drug: SB27; Drug: Keytruda Sponsors: Samsung Bioepis Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials